Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy

被引:143
作者
Topalian, Suzanne L. [1 ,3 ,4 ]
Forde, Patrick M. [2 ,3 ,4 ]
Emens, Leisha A. [5 ]
Yarchoan, Mark [2 ,3 ,4 ]
Smith, Kellie N. [2 ,3 ,4 ]
Pardoll, Drew M. [2 ,3 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21287 USA
[4] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA
[5] Ankyra Therapeut, Cambridge, MA 02142 USA
关键词
RESECTABLE HEPATOCELLULAR-CARCINOMA; PEMBROLIZUMAB PLUS CHEMOTHERAPY; OPEN-LABEL; LUNG-CANCER; STAGE-III; MISMATCH REPAIR; PD-1; BLOCKADE; OPACIN-NEO; HIGH-RISK; NIVOLUMAB;
D O I
10.1016/j.ccell.2023.07.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Among new treatment approaches for patients with cancer, few have accelerated as quickly as neoadjuvant immune checkpoint blockade (ICB). Neoadjuvant cancer therapy is administered before curative-intent surgery in treatment-naive patients. Conventional neoadjuvant chemotherapy and radiotherapy are primarily intended to reduce tumor size, improving surgical resectability. However, recent scientific evidence outlined here suggests that neoadjuvant immunotherapy can expand and transcriptionally modify tumor-specific T cell clones to enhance both intratumoral and systemic anti-tumor immunity. It further offers a unique "window of opportunity"to explore mechanisms and identify novel biomarkers of ICB response and resistance, opening possibilities for refining long-term clinical outcome predictions and developing new, more highly effective ICB combination therapies. Here, we examine advances in clinical and scientific knowledge gleaned from studies in select cancers and describe emerging key principles relevant to neoadjuvant ICB across many cancer types.
引用
收藏
页码:1551 / 1566
页数:16
相关论文
共 101 条
[1]  
Al-Batran SE, 2022, J CLIN ONCOL, V40
[2]   Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer [J].
Ali, Greta ;
Poma, Anello Marcello ;
Di Stefano, Iose ;
Zirafa, Carmelina Cristina ;
Lenzini, Alessandra ;
Martinelli, Giulia ;
Romano, Gaetano ;
Chella, Antonio ;
Baldini, Editta ;
Melfi, Franca ;
Fontanini, Gabriella .
FRONTIERS IN ONCOLOGY, 2023, 13
[3]   Neoadjuvant relatlimab and nivolumab in resectable melanoma [J].
Amaria, Rodabe N. ;
Postow, Michael ;
Burton, Elizabeth M. ;
Tezlaff, Michael T. ;
Ross, Merrick, I ;
Torres-Cabala, Carlos ;
Glitza, Isabella C. ;
Duan, Fei ;
Milton, Denai R. ;
Busam, Klaus ;
Simpson, Lauren ;
McQuade, Jennifer L. ;
Wong, Michael K. ;
Gershenwald, Jeffrey E. ;
Lee, Jeffrey E. ;
Goepfert, Ryan P. ;
Keung, Emily Z. ;
Fisher, Sarah B. ;
Betof-Warner, Allison ;
Shoushtari, Alexander N. ;
Callahan, Margaret ;
Coit, Daniel ;
Bartlett, Edmund K. ;
Bello, Danielle ;
Momtaz, Parisa ;
Nicholas, Courtney ;
Gu, Aidi ;
Zhang, Xuejun ;
Korivi, Brinda Rao ;
Patnana, Madhavi ;
Patel, Sapna P. ;
Diab, Adi ;
Lucci, Anthony ;
Prieto, Victor G. ;
Davies, Michael A. ;
Allison, James P. ;
Sharma, Padmanee ;
Wargo, Jennifer A. ;
Ariyan, Charlotte ;
Tawbi, Hussein A. .
NATURE, 2022, 611 (7934) :155-+
[4]   Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium [J].
Amaria, Rodabe N. ;
Menzies, Alexander M. ;
Burton, Elizabeth M. ;
Scolyer, Richard A. ;
Tetzlaff, Michael T. ;
Antdbacka, Robert ;
Ariyan, Charlotte ;
Bassett, Roland ;
Carter, Brett ;
Daud, Adil ;
Faries, Mark ;
Fecher, Leslie A. ;
Flaherty, Keith T. ;
Gershenwald, Jeffrey E. ;
Hamid, Omid ;
Hong, Angela ;
Kirkwood, John M. ;
Lo, Serigne ;
Margolin, Kim ;
Messina, Jane ;
Postow, Michael A. ;
Rizos, Helen ;
Ross, Merrick I. ;
Rozeman, Elisa A. ;
Saw, Robyn P. M. ;
Sondak, Vernon ;
Sullivan, Ryan J. ;
Taube, Janis M. ;
Thompson, John F. ;
van de Wiel, Bart A. ;
Eggermont, Alexander M. ;
Davies, Michael A. ;
Ascierto, Paolo A. ;
Spillane, Andrew J. ;
van Akkooi, Alexander C. J. ;
Wargo, Jennifer A. ;
Blank, Christian U. ;
Tawbi, Hussein A. ;
Long, Georgina V. .
LANCET ONCOLOGY, 2019, 20 (07) :E378-E389
[5]   Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study [J].
Andre, Thierry ;
Tougeron, David ;
Piessen, Guillaume ;
de la Fouchardiere, Christelle ;
Louvet, Christophe ;
Adenis, Antoine ;
Jary, Marine ;
Tournigand, Christophe ;
Aparicio, Thomas ;
Desrame, Jerome ;
Lievre, Astrid ;
Garcia-Larnicol, Marie-Line ;
Pudlarz, Thomas ;
Cohen, Romain ;
Memmi, Salome ;
Vernerey, Dewi ;
Henriques, Julie ;
Lefevre, Jeremie H. ;
Svrcek, Magali .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) :255-+
[6]  
[Anonymous], 2021, ONC DRUGS ADV COMM O
[7]   Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma [J].
Blank, Christian U. ;
Rozeman, Elisa A. ;
Fanchi, Lorenzo F. ;
Sikorska, Karolina ;
van de Wiel, Bart ;
Kvistborg, Pia ;
Krijgsman, Oscar ;
van den Braber, Marlous ;
Philips, Daisy ;
Broeks, Annegien ;
van Thienen, Johannes, V ;
Mallo, Henk A. ;
Adriaansz, Sandra ;
ter Meulens, Sylvia ;
Pronk, Loes M. ;
Grijpink-Ongering, Lindsay G. ;
Bruining, Annemarie ;
Gittelman, Rachel M. ;
Warren, Sarah ;
van Tinteren, Harm ;
Peeper, Daniel S. ;
Haanen, John B. A. G. ;
van Akkooi, Alexander C. J. ;
Schumacher, Ton N. .
NATURE MEDICINE, 2018, 24 (11) :1655-+
[8]   Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227 [J].
Brahmer, Julie R. ;
Lee, Jong-Seok ;
Ciuleanu, Tudor-Eliade ;
Bernabe Caro, Reyes ;
Nishio, Makoto ;
Urban, Laszlo ;
Audigier-Valette, Clarisse ;
Lupinacci, Lorena ;
Sangha, Randeep ;
Pluzanski, Adam ;
Burgers, Jacobus ;
Mahave, Mauricio ;
Ahmed, Samreen ;
Schoenfeld, Adam J. ;
Paz-Ares, Luis G. ;
Reck, Martin ;
Borghaei, Hossein ;
O'Byrne, Kenneth J. ;
Gupta, Ravi G. ;
Bushong, Judith ;
Li, Li ;
Blum, Steven I. ;
Eccles, Laura J. ;
Ramalingam, Suresh S. .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) :1200-+
[9]   Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial [J].
Cascone, Tina ;
Leung, Cheuk H. ;
Weissferdt, Annikka ;
Pataer, Apar ;
Carter, Brett W. ;
Godoy, Myrna C. B. ;
Feldman, Hope ;
William Jr, William N. ;
Xi, Yuanxin ;
Basu, Sreyashi ;
Sun, Jing Jing ;
Yadav, Shalini S. ;
Rojas Alvarez, Frank R. ;
Lee, Younghee ;
Mishra, Aditya K. ;
Chen, Lili ;
Pradhan, Monika ;
Guo, Haiping ;
Sinjab, Ansam ;
Zhou, Nicolas ;
Negrao, Marcelo V. ;
Le, Xiuning ;
Gay, Carl M. ;
Tsao, Anne S. ;
Byers, Lauren Averett ;
Altan, Mehmet ;
Glisson, Bonnie S. ;
Fossella, Frank V. ;
Elamin, Yasir Y. ;
Blumenschein, George ;
Zhang, Jianjun ;
Skoulidis, Ferdinandos ;
Wu, Jia ;
Mehran, Reza J. ;
Rice, David C. ;
Walsh, Garrett L. ;
Hofstetter, Wayne L. ;
Rajaram, Ravi ;
Antonoff, Mara B. ;
Fujimoto, Junya ;
Solis, Luisa M. ;
Parra, Edwin R. ;
Haymaker, Cara ;
Wistuba, Ignacio I. ;
Swisher, Stephen G. ;
Vaporciyan, Ara A. ;
Lin, Heather Y. ;
Wang, Jing ;
Gibbons, Don L. ;
Jack Lee, J. .
NATURE MEDICINE, 2023, 29 (3) :593-604
[10]   Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial [J].
Cascone, Tina ;
William, William N., Jr. ;
Weissferdt, Annikka ;
Leung, Cheuk H. ;
Lin, Heather Y. ;
Pataer, Apar ;
Godoy, Myrna C. B. ;
Carter, Brett W. ;
Federico, Lorenzo ;
Reuben, Alexandre ;
Khan, Md Abdul Wadud ;
Dejima, Hitoshi ;
Francisco-Cruz, Alejandro ;
Parra, Edwin R. ;
Solis, Luisa M. ;
Fujimoto, Junya ;
Tran, Hai T. ;
Kalhor, Neda ;
Fossella, Frank V. ;
Mott, Frank E. ;
Tsao, Anne S. ;
Blumenschein, George, Jr. ;
Le, Xiuning ;
Zhang, Jianjun ;
Skoulidis, Ferdinandos ;
Kurie, Jonathan M. ;
Altan, Mehmet ;
Lu, Charles ;
Glisson, Bonnie S. ;
Byers, Lauren Averett ;
Elamin, Yasir Y. ;
Mehran, Reza J. ;
Rice, David C. ;
Walsh, Garrett L. ;
Hofstetter, Wayne L. ;
Roth, Jack A. ;
Antonoff, Mara B. ;
Kadara, Humam ;
Haymaker, Cara ;
Bernatchez, Chantale ;
Ajami, Nadim J. ;
Jenq, Robert R. ;
Sharma, Padmanee ;
Allison, James P. ;
Futreal, Andrew ;
Wargo, Jennifer A. ;
Wistuba, Ignacio I. ;
Swisher, Stephen G. ;
Lee, J. Jack ;
Gibbons, Don L. .
NATURE MEDICINE, 2021, 27 (03) :504-+